Actor turned rare disease advocate Luke Rosen tells how his daughter, Susannah, lives with a KIF1A-associated neurological ...

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

Please provide your email address to receive an email when new articles are posted on . There are approximately 500 full-time fellowship-trained neuro- ophthalmologists in the U.S. to care for a ...

Please provide your email address to receive an email when new articles are posted on . Biopharmaceutical company Karuna Therapeutics has announced an exclusive license agreement with biotech firm ...

ALISO VIEJO, Calif., March 19, 2025 /PRNewswire/ — Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, proudly marks the 15th anniversary of ...

Neurological autoimmune diseases involve an immune system attack on the central or peripheral nervous system (PNS). Multiple sclerosis is the most common and well-known of these conditions, but ...

ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of ...

New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases Amsterdam, ...

Understanding the differences and similarities between neurological disorders and neurodegenerative diseases can be important when offering or accessing healthcare. It is also important for scientific ...

LOUISVILLE, Ky. (WDRB) -- A groundbreaking treatment for substance use disorder is changing lives by using neuro-stimulation, and it’s exclusively available in the Louisville area. For Teddy Edenstrom ...

Carsten Schroeder, President and CEO of Terumo Neuro, commented on this significant milestone: "The WEB device has set a new standard in aneurysm treatment and has been instrumental in our mission to ...